TABLE 1 from Tusamitamab Ravtansine in Patients with Advanced Solid Tumors: Phase I Study of Safety, Pharmacokinetics, and Antitumor Activity Using Alternative Dosing Regimens
收藏数据链接：
官方服务：
资源简介：
Baseline demographics and disease characteristics by DL in cohorts Q2W-LD and Q3W (all-treated/safety population)
创建时间：
2023-08-28
